Aesthetics & Med Spas

Turn Instagram inquiries into consultations, with advertising rules built in

We build inquiry, follow-up and rebooking systems for aesthetic clinics. Practitioners decide what is said about treatments, and every consent stays on record.

Short answer

How can AI help an aesthetic clinic or med spa?

AI helps most in the work around the treatment room: answering inquiries quickly, offering consultation slots, chasing unbooked consultations, prompting rebooking and drafting aftercare for practitioner approval. It does not choose treatments, prescribe or judge suitability. Those decisions stay with licensed practitioners, and every advertising claim still needs a person who knows the rules.

Who this covers

Organizations in this segment

  • Independent aesthetic clinics run by doctors, nurse prescribers or other registered practitioners
  • US medical spas working under a supervising physician or medical director
  • UK facial aesthetics practitioners and small clinic groups
  • Multi-location laser, skin and injectables brands with central marketing
Challenges

The business problems that hold this segment back

01

Inquiries arrive in five places at once

Instagram messages, forms, missed calls, texts and email are answered at different speeds depending on who is on shift. A slow reply gives the inquiry time to go elsewhere.

02

The consultation carries both the sale and the clinical judgment

A coordinator wants the booking, while the practitioner must decide whether the person is a suitable candidate. Price-led inquiries and no-shows consume practitioner time.

03

Rebooking depends on memory

Many aesthetic treatments are repeat visits, but recall often relies on a coordinator noticing who is due. Clients drift elsewhere when nobody reaches out.

04

Advertising rules limit what you can say and who you can reach

In the UK, a post that names a prescription-only product can breach the CAP Code. US platforms treat interest in invasive cosmetic procedures as sensitive health data and restrict audiences.

05

Photos, consent and reviews fall under different rules

Before and after images should have documented permission for marketing use, separate from treatment consent. Review requests must avoid incentives tied to positive sentiment.

Where AI fits

Suitable AI, and how mature each application is

Established means widely deployed and well documented. Emerging means real deployments exist but results vary with your data and workflow. Early means pilots or research, not a safe default.

Established

Inquiry response and consultation booking

Bounded routing and booking is a mature patient access task, with evidence from general practice rather than aesthetics. A missed-call text or Instagram reply can offer two consultation slots and pass anything clinical to the practitioner. AI agents suit this because the task is narrow and the exits to a person are defined.

Established

Recall and rebooking sequences

Recall lists built from treatment type, last visit and practitioner are routine automation, with AI varying wording and timing. The limit is permission: promotional messages need consent, and a reminder should not quietly become an offer.

Emerging

Consultation preparation summaries

Intake forms and stated goals can be condensed into a one-page brief for the practitioner. It is emerging here because a 2026 US legal review describes AI in med-spa intake but gives no adoption percentage. The practitioner still reads the source form.

Emerging

Aftercare and check-in drafts

Aftercare can be drafted from clinic-approved templates and released by a nurse. Disclosure rules such as Texas TRAIGA (from 1 January 2026) may apply.

Emerging

Advertising and content pre-checks

A reviewer prompt can scan captions and ad copy against the clinic's rule list, such as no prescription-only product names in UK content. It catches slips and does not replace the person who approves each claim.

Early

Skin analysis and treatment previews

A 2026 legal review warns against presenting such tools as validated diagnosis, and a tool that works as a medical device may need authorization. We treat them as a conversation aid at most, after checking intended use.

What stays human

Responsibilities that stay with your people

Prescribers and practitioners

A doctor or nurse prescriber decides suitability, takes consent and prescribes. Since 1 June 2025 UK independent nurse and midwife prescribers must assess patients face to face first, so AI or video cannot stand in.

Medical director or clinic manager

Signs off treatment pages, ad copy and posts, and owns the rule list every AI draft is checked against.

Patient coordinator or front desk lead

Price conversations, nervous clients and complaints need judgment and warmth. AI handles slots and reminders.

Compliance lead or registered manager

Consent forms, photo permissions and retention are decided here, along with what each tool may access.

Improvements

Operational changes you can expect to work on

01

Faster first response after hours

Evening Instagram messages get an answer with real slots, and lead response time becomes a number to watch.

02

Fewer consultations lost to no-shows

Confirmations with easy rescheduling protect practitioner time, and show rate is tracked by channel.

03

Rebooking as a routine

Clients due a repeat visit hear from the clinic in wording the practitioner approved.

04

Consistent aftercare across practitioners

Every client gets the same approved instructions for the same treatment, and concerns reach a nurse the same day.

Commercial value

Where the revenue sits

Revenue comes from turning an inquiry into a consultation, the consultation into a treatment plan, and the client into a repeat visitor. Good revenue operations tighten each handoff while practitioners protect the clinic's reputation. Results depend on your baseline, treatment mix and team adoption.

  • Measure lead response time, inquiry-to-consultation rate, consultation-to-treatment rate and rebooking rate first.
  • Track booked consultations by channel using clinic-side records, not patient details sent to ad platforms.
  • Attract nearby searchers through local search, accurate profile details and rule-compliant review handling.
  • Send recall and offers only to clients who agreed to receive them.
Rules and limits

US and UK rules that apply, and what is not ready yet

General information for planning, not legal advice. Statuses and dates are as published at the time of writing.

United States

  • FTC Reviews and Testimonials Rule (effective 21 October 2024): bars fake or AI-invented reviews and incentives conditioned on sentiment. A HIPAA-regulated provider also needs a valid authorization before publishing an identifiable patient testimonial as marketing.
  • Platform policies (current as of October 2026): Google treats invasive cosmetic procedures as a sensitive health interest, so Customer Match cannot be used. Meta ads must not imply a viewer's condition or promise unrealistic appearance results.
  • A 2026 US legal review says AI treatment suggestions do not displace a licensed provider's judgment, delegation or supervision requirements.
  • TCPA (ongoing): automated marketing texts generally need prior express written consent, and the FCC ruled on 8 February 2024 that AI-generated voices are artificial voices.

United Kingdom

  • CAP Code rule 12.12 (ongoing): prescription-only medicines must not be advertised to the public. Advertise a consultation, not botulinum toxin. An ASA ruling of 9 July 2025 shows an unbranded reference to a drug class, such as a GLP-1 weight loss injection, can breach it.
  • Since 25 May 2022 cosmetic interventions must not be targeted at under-18s, and placements must avoid media where under-18s are 25% or more of the audience.
  • England's planned licensing scheme (government response 7 August 2025) has no confirmed commencement date as of 11 October 2026. Do not claim a license under it.
  • The DMCC Act bans fake and concealed incentivised reviews from 6 April 2025, and PECR generally requires consent for marketing email and SMS.
Not mature or not suitable yet
  • Client-facing treatment recommendations. They sit close to clinical judgment and device rules, so we would not deploy them without a practitioner and a proper AI governance review.
  • AI or video consultation in place of the face-to-face assessment UK prescribing rules require.
  • Outcome previews presented as predictions, which set expectations a treatment may not meet.
  • Adoption claims: no defensible US or UK adoption percentage exists for med-spa AI.
Where to start

Where we would begin

  1. 01

    Map every inquiry path and set the baseline

    We follow an inquiry from message, form or missed call to booked consultation and record today's response time and show rate. The same mapping helps medical clinics that offer aesthetics as a side service.

  2. 02

    Write the rule list with your medical director

    A short list of wording never used for prescription-only treatments, what needs sign-off, photo permissions and which questions go to a practitioner. Every AI draft is checked against it.

  3. 03

    Launch one channel, then add recall

    We begin with after-hours handling on one channel, with the coordinator reviewing escalations. Recall and aftercare follow once consent records are clean.

Questions

Frequently asked questions

Can AI reply to our Instagram messages?

Yes, for bounded tasks such as opening hours, locations and offering consultation slots. Anything about medication, complications or price negotiation goes to a person, and the first reply says an automated assistant is helping.

Can AI write our posts about Botox or fillers?

It can draft them, but a person approves each one. UK content must not promote prescription-only products to the public, so drafts are built around the consultation. US platform policies and FTC claims rules apply to every post.

Can AI ask for reviews and reply to them?

It can send requests and draft replies for approval. It must never write reviews or offer rewards for positive ones, because the FTC rule and the UK DMCC Act both target fake and incentivised reviews.

Do clients have to be told that AI is involved?

Often yes. Texas TRAIGA requires disclosure of AI use in a healthcare service by the first date of service, and California AB 3030 covers some generative-AI patient messages unless a licensed provider reviews them. Check with qualified counsel for your state; we build a plain disclosure into every chat anyway.

Does this work for a single-location clinic?

Yes, and it is often easier because one owner decides quickly. Larger brands face extra questions about shared data, which we cover for multi-site groups.

Start with one channel and one number

Tell us where inquiries reach you and which step loses the most people. We will map it and show you a first version.

Book a discovery call
error: Content is protected !!